GenXys Inks Software Deal with CareWell Health for Precision Medicine

GenXys Inks Software Deal with CareWell Health for Precision Medicine

Vancouver, Canada (June 20, 2023) – GenXys Health Care Systems, Inc., the global leader in precision prescribing software with embedded pharmacogenetic data, finalized another customer deal to advance precision medicine initiatives. This latest partnership, with New Jersey-based CareWell Health, will help them improve health outcomes by reducing the frequency and severity of adverse drug events, saving money for patients through tailored prescribing, and tracking important pharmacogenetic clinical statistics.  

CareWell Health, an innovative hospital with an internal molecular lab and pharmacy was named one of the top three hospitals in New Jersey and is at the cutting-edge of value-add for their patients. They offer a highly requested pharmacogenetics (PGx) plan and have a thorough process to implement clinical decision support systems for the benefit of their patients.  

GenXys’ award-winning precision prescribing software, with embedded PGx, will ensure new solutions for CareWell Health clinicians. It will also provide plug-and-play ability for a seamless connection between their laboratory and care teams while introducing automated medication review capabilities with PGx. GenXys will overlay its expertise with the delivery of a seamless connection and securitized data flow between laboratory information management systems, electronic health records, and other systems. It will also include patient health variables and interactions beyond PGx to provide absolute confidence in prescribing decisions.   

“GenXys is helping to make considerable changes in the way health systems approach precision medicine and adopt pharmacogenetics in community care,” says Karl Pringle, CEO of GenXys. “We are so pleased to support CareWell Health in their precision health drive, and to combine all patient data points necessary for accurate prescribing including PGx data automatically at any point of care.” 

GenXys is continuing the trend of landing high-quality health systems and molecular labs, accelerating their PGx adoption and building a substantial user base covering thousands of patients. 

“We are delighted to have the GenXys platform as an integral part of our precision medicine program. CareWell Health is embracing the era of precision medicine and it is important that our clinicians are able to use this relevant data at any point of care to provide the best patient outcomes.” says Paige Dworak, CEO of CareWell Health. 

Auto-analysis of genetic information with other medication interaction points is helping to transform the “trial-and-error” approach of prescribing to one of precision and accuracy. PGx is all about personalized, safe, and appropriate medication options being available at any point of care. CareWell Health is on a quest to revolutionize healthcare as we know it, and the partnership with GenXys is an advancement of technological and medicinal integration that supports the growth that PGx is striving towards to create a better future of medicine for all. 

 

### 

   

About GenXys Health Care Systems   

 GenXys, with a presence across North America, provides the world’s most comprehensive precision prescribing solutions with embedded pharmacogenetics to solve one of healthcare’s biggest challenges: inappropriate (“trial-and-error”) prescribing. GenXys’ clinical decision support software suite is in use by major insurance providers, health systems, pharmacies and their pharmacogenetic labs across North America. Ongoing global clinical studies are paving the way into geographical markets to enable GenXys to realize its vision of making every prescription better with its software to increase patient safety, improve population health, and reduce healthcare costs. genxys.com   

About CareWell Health 

CareWell Health is an independent acute-care hospital centrally located in East Orange, New Jersey, providing world-class care community care for the past few decades. Formerly known as East Orange General Hospital, this change represents their commitment to continue serving as a vital community asset for many decades to come. With this partnership with GenXys, CareWell Health will have access to expansive medication options and review capabilities in the GenXys platform for behavioral health and cardiology. 

Contact: 

Media Relations and Interview Requests: media@genxys.com